Key facts, as of
As of November 2, 2026, Thermo Fisher Scientific (TMO) trades at $685.90, up 20.9% over the past year. Its 52-week range runs from $435.27 to $711.85; the price is 3.6% below that high. It is 3.6% below its all-time high of $711.85, reached in October 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +387.7%, against +316.3% for the S&P 500 (SPY). It sits 24.3% above its 200-day average of $551.67, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 27.3% annualized, which we rate medium risk. It has a trailing P/E of 36.2 and a dividend yield of 0.27%.
Cite: Portfolio Terminal, "Thermo Fisher Scientific (TMO) stock analysis", 2026-11-02. https://portfolio-terminal.com/analyse/tmo
Where it trades today
trading 91% of the way up its 52-week range
How the price has moved
How far it is from its record
Thermo Fisher Scientific (TMO) is 3.6% below its all-time high of $711.85, reached in October 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +387.7%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- TMO closes above its 50-day average ($655.78), and the 50-day sits above the 200-day ($551.67): on both averages the chart reads as an uptrend.
- At $685.90, TMO is 3.6% below its 1-year high of $711.85, set on October 29, 2026, and 57.6% above its 1-year low of $435.27 (May 18, 2026).
- Over the past month TMO rose 4.7%, from $654.80 to $685.90.
- TMO trades at 36.2x its last twelve months of earnings and 24.7x the next twelve months' estimate, so analysts expect earnings 46.5% higher.
- Its P/E is in line with the 38.0x median of the 3 other diagnostics & research companies we track (DHR, A, WAT).
- TMO's 30-day volatility, 27.3% a year, works out to a typical daily move of about 1.7%.
- Yahoo Finance puts its beta at 0.84: over five years of monthly returns, TMO moved about 0.84% for each 1% move of the S&P 500.
- The last session traded 0.4x TMO's average daily volume of the 30 sessions before it.
What would change the read
- A close under the 50-day average, $655.78 (−4.4% from the last close), would turn the read to a pullback; under the 200-day, $551.67 (−19.6%), the longer rise is in question.
- A close above $711.85 (+3.8%) would be a new 1-year high; below $435.27 (−36.5%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for TMO, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under diagnostics & research among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for TMO by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for TMO. Last refresh: Nov 2, 2026, 7:10 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Diagnostics & Research.
What Thermo Fisher Scientific does
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government,…
Employees
125,000
Industry
Diagnostics & Research
Headquarters
Waltham, United States
What analysts expect
TMO carries a strong buy consensus from 25 analysts, with an average price target of $752.12 versus $685.90 today (+9.7%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
TMO generated $47.35B in trailing revenue (9.1% year over year), with a 14.9% net margin, and $6.44B of free cash flow, against $35.31B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $44.56B | $18.24B | $8.11B | $6.70B | $17.77 | $6.29B |
| 2024 | $42.88B | $17.70B | $7.72B | $6.33B | $16.58 | $7.27B |
| 2023 | $42.86B | $17.10B | $7.32B | $6.00B | $15.52 | $6.93B |
| 2022 | $44.91B | $18.97B | $8.51B | $6.95B | $17.75 | $6.91B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
TMO is in 16 of the 54 ETFs we track. It weighs most in XLV: 3.98% of the fund, holding #6 of 62.
Famous investors who hold it
TMO is in the latest 13F of 1 of the 15 famous investors we follow. Stanley Druckenmiller (Duquesne Family Office) holds the most of it: 0.18% of the portfolio, position #76 of 94, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
TMO beside the other companies Yahoo Finance files under diagnostics & research among the assets we track (DHR, A, WAT, largest first).
TMOyou are here$685.90$254.14B
AAgilent Technologies$172.93$48.76B
WATWaters Corporation$452.01$44.38BWhat the chart is saying
In an uptrend, 3.6% under its 1-year high with no resistance above.
uptrend- Price is 4.6% above its 50-day average and 24.3% above its 200-day.
- The 50-day crossed above the 200-day on 2026-08-18 (a “golden cross”).
- RSI at 54 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $645.49 (-5.9%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is TMO valued right now?
Thermo Fisher Scientific trades at 36.2 times its last twelve months of earnings and 24.7 times the next twelve months' estimate (Yahoo Finance, November 2, 2026). On the chart: in an uptrend, 3.6% under its 1-year high with no resistance above. Price is 4.6% above its 50-day average and 24.3% above its 200-day.
What is the risk level of TMO?
Based on 30-day volatility of 27.3%, TMO has MEDIUM risk. Its beta of 0.84 means it has swung less than the S&P 500 over the last five years.
Does TMO pay dividends?
Yes, Thermo Fisher Scientific has a dividend yield of 0.27%.
How far is TMO from its all-time high?
Thermo Fisher Scientific is 3.6% below its all-time high of $711.85, reached in October 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +387.7%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold TMO?
16 of the 54 popular ETFs we track hold Thermo Fisher Scientific. The largest weights: XLV (3.98%), VTV (0.95%), SPY (0.39%), CSPX (0.39%) and IVV (0.39%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is TMO?
0.38%, as of September 30, 2026: TMO is holding #45 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $3.79 in Thermo Fisher Scientific.
Which famous investors own TMO?
Stanley Druckenmiller (0.18% of Duquesne Family Office's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for TMO?
The average analyst price target for Thermo Fisher Scientific (TMO) is $752.12 based on 25 analyst estimates, about 9.7% above the current price of $685.90. The published range runs from $590.00 to $830.00.
How much revenue does TMO generate?
Thermo Fisher Scientific reported $47.35B in trailing twelve-month revenue. Revenue growth is running at 9.1% year over year. Net margin sits at 14.9%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare TMO with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.